CRINETICS PHARMACEUTICALS IN
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for CRINETICS PHARMACEUTICALS IN COM, CUSIP 22663K957.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for CRINETICS PHARMACEUTICALS IN COM, CUSIP 22663K957.